Ironically , the Task Force recommendation isn ' t too far apart from that of the American Urologic Association , which represents most of the doctors who diagnose and treat prostate cancer . The association ' s 2009 publication titled " PSA Screening Best Practice " reads : " Given the uncertainty that PSA testing results in more benefit than harm , a thoughtful and broad approach to PSA is critical . Patients need to be informed of the risks and benefits of testing before it is undertaken . The risks of overdetection and overtreatment should be included in this discussion . "
